Clinical trial
Gemcitabine and Oxaliplatin as Second-Line Therapy in Treating Patients With…
NCT00305786 · University of Miami, Other · Completed
Key facts
| NCT number | NCT00305786 |
|---|---|
| Title | Gemcitabine and Oxaliplatin as Second-Line Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer |
| Official title | Phase II Study of Oxaliplatin in Combination With Gemcitabine for 2 Line Treatment of NSCLC Patients With Advanced and Metastatic Disease |
| Lead sponsor | University of Miami, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Lung Cancer |
| Intervention type | Drug |
| Interventions | gemcitabine hydrochloride, oxaliplatin |
| Enrollment | 30 |
| Start date | Aug 1, 2005 |
| Primary completion | Dec 1, 2007 |
| Completion | May 1, 2010 |
| First posted | Mar 22, 2006 |
| Last update posted | Dec 15, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: